Apotex Sues Merck Over Lost Sales Of Generic Fosamax
Canadian drug maker Apotex Inc. has sued Merck & Co. for damages for lost sales of a generic version of osteoporosis drug Fosamax....To view the full article, register now.
Already a subscriber? Click here to view full article